/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
Valued at $35.3 billion by market cap, San Diego, California-based ResMed Inc. (RMD) develops, manufactures, distributes, and markets medical devices and cloud-based software applications for healthcare. The medical device company is expected to announce its first-quarter earnings for fiscal 2025 after the market closes on Thursday, Oct. 24.
Ahead of the event, analysts expect RMD to report a profit of $2.03 per share on a diluted basis, up 23.8% from $1.64 per share in the year-ago quarter. The company beat the consensus estimates in each of the last four quarters. During the previous quarter, consistent patient and customer demand for the company’s products and software solutions remained robust. As a result, its EPS of $2.08 surpassed the consensus estimate by 2.5%,